We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INGN icon
5051
Inogen
INGN
$164M
$460K ﹤0.01%
56,622
+35,060
+163% +$271K
NFBK
5052
DELISTED
Northfield Bancorp
NFBK
$456K ﹤0.01%
48,125
+10,567
+28% +$92.6K
CRGX
5053
DELISTED
CARGO Therapeutics
CRGX
$456K ﹤0.01%
27,776
-18,799
-40% -$357K
GSHD icon
5054
Goosehead Insurance
GSHD
$2.32B
$455K ﹤0.01%
7,917
-34,691
-81% -$2.08M
GBF icon
5055
iShares Government/Credit Bond ETF
GBF
$128M
$453K ﹤0.01%
4,412
+123
+3% +$12.6K
IHD
5056
Voya Emerging Markets High Income Dividend Equity Fund
IHD
$131M
$453K ﹤0.01%
84,189
+2,740
+3% +$14.4K
VXX icon
5057
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
$453K ﹤0.01%
10,369
+1,063
+11% +$53K
AWP
5058
abrdn Global Premier Properties Fund
AWP
$367M
$452K ﹤0.01%
39,470
-14,107
-26% -$159K
FLNC icon
5059
CALL
Fluence Energy
FLNC
$2.44B
$451K ﹤0.01%
+26,000
New +$499K
TOLZ icon
5060
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$174M
$450K ﹤0.01%
10,006
+4,211
+73% +$192K
BSJU icon
5061
Invesco BulletShares 2030 High Yield Corporate Bond ETF
BSJU
$315M
$449K ﹤0.01%
17,698
+249
+1% +$6.34K
DFH icon
5062
Dream Finders Homes
DFH
$1.36B
$449K ﹤0.01%
17,397
-28,995
-63% -$917K
EVTR icon
5063
Eaton Vance Total Return Bond ETF
EVTR
$5.73B
$449K ﹤0.01%
9,043
-13,602
-60% -$671K
ZEUS
5064
DELISTED
Olympic Steel
ZEUS
$449K ﹤0.01%
10,009
-1,038
-9% -$59.3K
IMCR icon
5065
Immunocore
IMCR
$1.73B
$447K ﹤0.01%
13,199
-81
-0.6% -$4.13K
BCAL icon
5066
Southern California Bancorp
BCAL
$682M
$447K ﹤0.01%
33,161
+821
+3% +$11.4K
VIRC icon
5067
Virco
VIRC
$96.3M
$446K ﹤0.01%
32,019
+23,869
+293% +$296K
MRCC
5068
DELISTED
Monroe Capital Corp
MRCC
$446K ﹤0.01%
58,563
+2,671
+5% +$19.7K
BSJT icon
5069
Invesco BulletShares 2029 High Yield Corporate Bond ETF
BSJT
$578M
$446K ﹤0.01%
21,258
+149
+0.7% +$3.13K
FJAN icon
5070
FT Vest US Equity Buffer ETF January
FJAN
$1.46B
$445K ﹤0.01%
10,249
+7,799
+318% +$330K
GWRS icon
5071
Global Water Resources
GWRS
$219M
$445K ﹤0.01%
36,765
-8,775
-19% -$109K
WULF icon
5072
CALL
TeraWulf
WULF
$8.52B
$444K ﹤0.01%
+99,800
New +$269K
CTKB icon
5073
Cytek Biosciences
CTKB
$546M
$444K ﹤0.01%
79,532
-3,375
-4% -$20.3K
PHAT icon
5074
Phathom Pharmaceuticals
PHAT
$692M
$444K ﹤0.01%
43,086
-6,837
-14% -$70.4K
TTGT icon
5075
TechTarget
TTGT
$278M
$444K ﹤0.01%
14,237
-9,701
-41% -$288K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.